Norvasc and Vaginal yeast infection - a phase IV clinical study of FDA data

Summary:

Vaginal yeast infection is found among people who take Norvasc, especially for people who are 60+ old.

The phase IV clinical study analyzes which people take Norvasc and have Vaginal yeast infection. It is created by eHealthMe based on reports of 128,409 people who have side effects when taking Norvasc from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 11, 2022

128,409 people reported to have side effects when taking Norvasc.
Among them, 16 people (0.01%) have Vaginal yeast infection.

What is Norvasc?

Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 131,576 Norvasc users for its effectiveness, alternative drugs and more.

What is Vaginal yeast infection?

Vaginal yeast infection is found to be associated with 613 drugs and 269 conditions by eHealthMe.

Number of Norvasc and Vaginal yeast infection reports submitted per year:

Could Norvasc cause Vaginal yeast infection?

Age of people who have Vaginal yeast infection when taking Norvasc *:

Common drugs people take besides Norvasc *:

Common side effects people have besides Vaginal yeast infection *:

Vision Blurred: 7 people, 43.75%
Urination - Excessive Volume: 7 people, 43.75%
Thirst - Excessive: 7 people, 43.75%
High Blood Cholesterol: 6 people, 37.50%
Urinary Tract Infection: 3 people, 18.75%
Muscle Spasms (muscle contraction): 3 people, 18.75%
Vaginitis (inflammation of the vagina): 3 people, 18.75%
Vaginal Discharge: 3 people, 18.75%
Electrocardiogram St Segment Abnormal: 2 people, 12.50%
Clamminess (moist, sticky, and cold to the touch): 2 people, 12.50%

Common conditions people have *:

Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 12.50%
Osteoporosis (bones weak and more likely to break): 1 person, 6.25%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.25%
Delusion (a false belief or opinion): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Norvasc and have Vaginal yeast infection?

Check whether Vaginal yeast infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Vaginal yeast infection and when was it recovered:

Vaginal yeast infection in Norvasc

Expand to all the drugs that have ingredients of amlodipine besylate:

Vaginal yeast infection and drugs with ingredients of amlodipine besylate (18 reports)

Alternative drugs to, pros and cons of Norvasc:

Norvasc (131,576 reports)

Common Norvasc side effects:

High blood pressure: 9,886 reports
Fatigue (feeling of tiredness): 7,134 reports
Weakness: 7,052 reports
Breathing difficulty: 7,011 reports
Pain: 6,152 reports
Diarrhea: 6,053 reports

Browse all side effects of Norvasc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Vaginal yeast infection treatments and more:

Vaginal yeast infection (1,772 reports)

COVID vaccines that are related to Vaginal yeast infection:

All the drugs that are associated with Vaginal yeast infection:

Vaginal yeast infection (613 drugs)

All the conditions that are associated with Vaginal yeast infection:

Vaginal yeast infection (269 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Norvasc) and Norvasc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.